Impact on Prevalence of the Application of NAFLD/MAFLD Criteria in Overweight and Normal Weight Patients.

Ana Luisa Ordoñez-Vázquez Eva Juárez-HernándezJulia María Zuarth-VázquezMartha Helena Ramos-OstosMisael UribeGraciela E Castro NarroIván López-Méndez

Published in: International journal of environmental research and public health (2022)

The application of NAFLD/MAFLD criteria did not show prevalence differences in overweight patients. With MAFLD criteria, the prevalence is lower in lean patients, but patients with high risk of progression of liver disease for steatosis were identified, according to their metabolic abnormalities.

Keyphrases

end stage renal disease
ejection fraction
risk factors
weight loss
physical activity
peritoneal dialysis
type diabetes
insulin resistance
metabolic syndrome
body composition
patient reported